30% incentive for substitutive dispensing proven drugs of bio-equivalency.

Effective from July 1 an incentive as much as about 30% of the price balance from the upper limit insurance price will be given to pharmacies when dispensing inexpensive substitutive drug already proven of its bio-equivalency from its original product.

The MOHW decided the medication saving plans by employing the above substitutive dispensing measure in the meeting of the NHI Review Arbitra...